Stockreport

XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update [Canadian Business Journal (Canada)]

XORTX Therapeutics Inc.  (XRTX) 
PDF CALGARY, Alberta, Dec. 31, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“CompanyHistorically, high uric acid concentration in the blood has been associated with incr [Read more]